CONCERTA
Methylphenidate hydrochloride
- Strength
- 36 mg/1
- Form
- Tablet, Extended Release
- Class
- Central Nervous System Stimulant
Janssen Pharmaceuticals, Inc.
Not stocked by us — reference only
Listed by Rhodes Pharmaceuticals LLC
| Dosage form | Capsule, Extended Release |
|---|---|
| Route | Oral |
| Drug class | Central Nervous System Stimulant |
| Approval route | Authorised generic |
| NDC code | 42858-079 |
| FDA application | NDA205831 |
| RxNorm concept | 1648183 |
| Package sizes listed | 1 |
| Marketed since | April 2020 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Methylphenidate hydrochloride
Janssen Pharmaceuticals, Inc.
Not stocked by us — reference only
Methylphenidate hydrochloride
Janssen Pharmaceuticals, Inc.
Not stocked by us — reference only
Methylphenidate hydrochloride
Janssen Pharmaceuticals, Inc.
Not stocked by us — reference only
Methylphenidate hydrochloride
Janssen Pharmaceuticals, Inc.
Not stocked by us — reference only
Methylphenidate
Neos Therapeutics Brands, LLC
Not stocked by us — reference only
Methylphenidate
Neos Therapeutics Brands, LLC
Not stocked by us — reference only
Methylphenidate
Neos Therapeutics Brands, LLC
Not stocked by us — reference only
methylphenidate
Noven Therapeutics, LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.